Topline Results from Phase 2 CELIA Study of Diranersen : First Study to Show Reduction in Tau Pathology and Cognitive Benefit in Patients with Early Alzheimer's Disease
Biogen to Acquire Apellis, Enhancing the Company's Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology
Metals Australia Limited Announces Participation in THE Mining Investment Event, Quebec City, June 2-4, 2026
Homeland Nickel Announces Environmental Studies to Commence at Cleopatra, Red Flat, Woodcock Mountain and Eight Dollar Mountain
NevGold Commences 20,000 Meter Drill Program at Antimony-Gold Limo Butte Project, Nevada; Streamlined Focus on Resource Building, Expansion, and New Discoveries
